| CIHR Institutes |
| ICRH Home |
| About ICRH |
| Research Priorities |
| Scientific Director |
| Advisory Board |
| ICRH Funding |
| ICRH Publications & Resources |
| ICRH Calendar of Events |
| Contact ICRH |
Dr. Peter Liu is the Heart & Stroke/Polo Chair Professor of Medicine and Physiology at the Toronto General Hospital Research Institute, University Health Network. He was appointed Scientific Director of the CIHR Institute of Circulatory and Respiratory Health in 2006.
Dr. Liu graduated from the University of Toronto Faculty of Medicine. During his medical training he undertook a research clerkship at Brigham and Women's Hospital in Boston, studying infarct remodeling and heart failure. During his cardiology training, he also pursued a post-doctoral fellowship in cardiovascular imaging and immunology at the Massachusetts General Hospital of Harvard Medical School, and clinical epidemiology at McMaster University. In 1985 he joined the Division of Cardiology at the Toronto General Hospital, University of Toronto. Since 1999, he has been the Heart & Stroke/Polo Chair Professor at the University Health Network and serves as Director of the Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research at the University of Toronto. The latter coordinates cardiovascular research and promotes mentorship and training of next generation of cardiovascular research leaders.
Dr. Liu focuses his research on the pathophysiology and clinical outcomes of heart failure from bench to bedside. His team has elucidated the role of inflammation in changing heart structure and function, and potential novel treatment targets in heart failure. His laboratory has also identified how viruses and bacteria can accelerate heart failure and coronary artery disease, and is developing novel vaccines to prevent these complications. With support from Genome Canada, CIHR group and team programs, and the Heart & Stroke Foundation, he is also pursuing novel biomarkers and therapeutic targets for early cardiovascular disease identification. He has published over 240 peer reviewed articles in high impact journals, contributed to 19 book chapters and collective works. In addition, he co-chaired a series of Canadian Cardiovascular Society Consensus Guideline Recommendations for heart failure care.
He is the recipient of numerous awards in recognition of his scientific contributions and accomplishments including the Rick Gallop Research Award Recognizing Research Excellence from the Heart & Stroke Foundation of Ontario (2003), the Research Achievement Award from the Canadian Cardiovascular Society (2003), Visiting Research Professor Award from the Royal College of Physicians and Surgeons (2005), and the Extramural Award of Merit from the American College of Cardiology (2005), amongst others. He has served as the scientific program chair for both the Canadian Cardiovascular Society and the Heart Failure Society of America scientific sessions and as chair for several CIHR and NIH scientific review panels. Most recently, he was asked by HUPO (Human Proteome Organization) to co-chair the 6th International Initiative on Global Cardiovascular Proteomics.
[ Biography | Welcome Message | Message on Transition ]
